Posted inNews FDA-approved ALS drug Relyvrio fails trial, faces removal from market One of the few drugs available to treat amyotrophic lateral sclerosis, or ALS, may be taken off the market after failing in a large clinical… Posted by By Jhon March 8, 2024Posted inNews